SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001408617-09-000013
Filing Date
2009-01-22
Accepted
2009-01-22 17:30:02
Documents
1
Period of Report
2009-01-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 6542
  Complete submission text file 0001408617-09-000013.txt   8486
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NPS PHARMACEUTICALS 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address C/O DONDRITE INTERNATIONAL INC 200 SOMERSET CORP BLVD BRIDGEWATER NJ 08807 9084505300
BESHAR LUKE M (Reporting) CIK: 0001192128 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23272 | Film No.: 09539925